News for KetamineOne Capital Limited (KONEF)

Castlebar Capital Corp. is pleased to announce that it has entered into an option agreement dated June 7, 2024 with Mosaic Minerals Corporation , pursuant to which Castlebar will be granted an...

The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business landscape.

The Company’s Wholly Owned Contract Research Organization has Been Engaged by Lophos Pharmaceuticals to Evaluate a Path to Market for Sustainably Grown,...

Revenue Exceeded $1.6 Million for the Period Ended January 31, 2022...

The Company’s Chief Research Officer and President of its Wholly Owned Subsidiary, KGK Science, Will Take Over for Adam Deffett who has Served as Interim CEO…

The Company’s Receipt of Approval for the Multidisciplinary “Reactivation” Program Designed by its Wholly Owned Subsidiary is a Major Milestone That is...

The Treatment was Successfully Performed in Ontario as Part of the Company’s Previously Announced Collaboration with Victoria Wellness and iHealthOX...

The Company’s Wholly Owned Contract Research Organization is Currently Working on Numerous Psychedelic Drug Projects, Clinical Trials, Path-to-Market…

VANCOUVER, British Columbia, Feb. 02, 2022 -- Wellbeing Digital Sciences Inc. , an evidence-based healthcare company focused on innovative clinical solutions, artificial... | February 2, 2022

The Companies Plan to Jointly Submit a Psilocybin Clinical Trial Application to Health Canada

New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB:

Utilizing its Previously Announced Partnership with iHealthOX, the Company Will Provide Initial Assessments and Consultations of, Develop Care Plans for and…

Utilizing its Previously Announced Partnership with iHealthOX, the Company Will Provide Initial Assessments and Consultations of, Develop Care Plans for...

The Up-Listing of the Company’s Common Shares to the OTCQB Coincides with its Recent Receipt of DTC Eligibility, which Enhances the Ability of US Investors to…

Psychedelic Science 2023, Taking Place in Denver, Colorado from June 19-25, is Being Planned as the World’s Largest Gathering of the Psychedelic Ecosystem,…

Psychedelic Science 2023, Taking Place in Denver, Colorado from June 19-25, is Being Planned as the World’s Largest Gathering of the Psychedelic Ecosystem,...

Revenues Reached Just Under $2.0 Million for the Quarter Ended October 31, 2021

VANCOUVER, British Columbia, Dec. 16, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC: KONEF)